Determination of erythrocyte Glutathione S-Transferase activity in individuals with gastric and colon cancer
1 Department of Biology, Sivas Cumhuriyet University, Faculty of Science, Sivas, Turkey.
2 Department of Pharmaceutical Botany, Sivas Cumhuriyet University, Faculty of Pharmacy, Sivas, Turkey.
Research Article
GSC Biological and Pharmaceutical Sciences, 2022, 20(03), 192–197.
Article DOI: 10.30574/gscbps.2022.20.3.0357
Publication history:
Received on 04 August 2022; revised on 13 September 2022; accepted on 15 September 2022
Abstract:
Glutathione-S-Transferase (GST) in human cells has great importance in the detoxification mechanism of carcinogenic chemicals. Therefore, (GST) may be a useful tumor marker. This study examines whether GST activity in Gastric cancer (GC) and Colon Cancer (CC) is a helpful marker in diagnosing and monitoring the disease course. GST activity was investigated in patients with CC and GC and healthy individuals.
Erythrocyte isolation was performed in 3 ml blood samples from volunteers aged 18-75 years. Hemoglobin amounts were determined from the standard graph drawn by monitoring the conversion of methemoglobin to cyanmethemoglobin in the presence of cyanide at 540 nm. Glutathione S-transferase activity was determined by measuring the amount of enzyme that catalyzes 1 µmol of S-(2,4-dinitrophenyl) glutathione formed per minute using 1-Chloro-2,4-Dinitrobenzene. The mean values of GST activities of patients with CC and GC, respectively; (1.28 ± 0.23 U/gHb; 1.20 ± 0.30 U/gHb), were significantly higher when compared to the mean values of healthy individuals with GST activity (0.59 ± 0.13 U/gHb) (p < 0.05). The GST activity of patients with colon cancer, measured as (1.56 ± 0.13 U/gHb) after chemotherapy, was significantly higher than before (1.09 ± 0.12 U/gHb) (p < 0.05). GST activity measured as (1.53± 0.24 U/gHb) after chemotherapy in gastric cancer patients was significantly higher when compared to the value measured before chemotherapy (0.97± 0.12 U/gHb) (p < 0.05). Our results show that the change in GST activity in CC and GC can be used as a biomarker to monitor the disease course and response to chemotherapy.
Keywords:
Colon cancer; Gastric cancer; Glutathione S-Transferase; Biomarker
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
